Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model

Clinical trial NCT01527188 · COMPLETED

Trial details

NCT number: NCT01527188
Sponsor: Stallergenes Greer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis Due to House Dust Mite

Start date: 2010-12-08
Primary completion: 2012-03-01
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.